The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Objective: The purpose of this study was to review the efficacy of estrogen therapy for urinary incontinence by examining published trials and to review the epidemiologic and physiologic evidence for its action. Data Source: Controlled and uncontrolled trials of estrogen therapy in the English literature were collected. Eight controlled and 14 uncontrolled trials were identified. Methods of Study Selection: Trials were selected if they were prospective. All types of estrogen treatment were included. All types of outcome measurements were included. Data Extraction and Synthesis: Trials were categorized by type of estrogen used; outcome variables (subjective improvement vs. objective urodynamic data); and cure/improvement rates. Conclusions: Published trials do not support estrogen replacement as efficacious therapy for stress urinary incontinence. It may be useful for incontinence associated with urgency and frequency. Adequately large controlled trials that evaluate estrogen replacement regimens used in the USA remain to be done.
Department of Reproductive Biology, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, Department of Obstetrics and Gynecology, 2074 Abington RoadCleveland, Ohio 44106USA